Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-16 5:30 pm Purchase |
2025-04-09 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,360,000 5.500% |
3,360,000 (New Position) |
Filing History |
| 2025-04-11 5:57 pm Purchase |
2025-04-04 | 13G | Aura Biosciences, Inc. AURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,057,319 6.100% |
3,057,319 (New Position) |
Filing History |
| 2025-04-11 4:46 pm Purchase |
2025-04-07 | 13G | DBV Technologies S.A. DBVT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 15,176,015 9.900% |
15,176,015 (New Position) |
Filing History |
| 2025-03-28 4:50 pm Purchase |
2025-03-26 | 13D | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 15,623,659 49.900% |
1,293,722 (+9.03%) |
Filing History |
| 2025-03-11 7:22 pm Purchase |
2025-03-04 | 13G | Aadi Bioscience, Inc. AADI |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,727,510 9.990% |
4,727,510 (New Position) |
Filing History |
| 2025-02-13 8:15 pm Sale |
2024-12-31 | 13G | Kura Oncology, Inc. KURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,198,189 6.700% |
-2,274,154 (-30.43%) |
Filing History |
| 2025-02-13 8:09 pm Sale |
2024-12-31 | 13G | Erasca, Inc. ERAS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 12,315,004 4.400% |
-1,453,035 (-10.55%) |
Filing History |
| 2025-02-13 8:00 pm Purchase |
2024-12-31 | 13G | 89bio, Inc. ETNB |
SUVRETTA CAPITAL MANAGEMENT, LLC | 10,202,696 8.500% |
2,211,052 (+27.67%) |
Filing History |
| 2025-02-11 8:51 pm Purchase |
2025-02-04 | 13G | Immatics N.V. IMTX |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,881,608 6.500% |
7,881,608 (New Position) |
Filing History |
| 2025-02-11 8:45 pm Purchase |
2025-02-07 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,022,612 5.500% |
917,348 (+43.57%) |
Filing History |
| 2025-02-11 8:20 pm Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,105,264 3.800% |
-3,358,377 (-61.47%) |
Filing History |
| 2025-02-07 5:36 pm Purchase |
2025-02-05 | 13G | PepGen Inc. PEPG |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,660,932 5.100% |
486,611 (+41.44%) |
Filing History |
| 2025-02-07 5:16 pm Sale |
2024-12-31 | 13G | PepGen Inc. PEPG |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,174,321 3.600% |
-486,611 (-29.30%) |
Filing History |
| 2025-01-06 4:50 pm Purchase |
2024-12-27 | 13G | Fulcrum Therapeutics, Inc. FULC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,404,612 6.300% |
2,221,821 (+187.85%) |
Filing History |
| 2024-12-20 4:56 pm Purchase |
2024-12-13 | 13G | Palvella Therapeutics, Inc. PVLA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 714,463 8.600% |
714,463 (New Position) |
Filing History |
| 2024-12-04 4:32 pm Purchase |
2024-11-26 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,040,365 6.100% |
2,040,365 (New Position) |
Filing History |
| 2024-11-18 4:36 pm Purchase |
2024-11-14 | 13D | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 14,329,937 49.900% |
5,500,884 (+62.30%) |
Filing History |
| 2024-11-14 4:28 pm Purchase |
2024-09-30 | 13G | Zura Bio Limited ZURA |
SUVRETTA CAPITAL MANAGEMENT, LLC | 4,860,939 7.600% |
2,010,939 (+70.56%) |
Filing History |
| 2024-11-14 4:25 pm Sale |
2024-09-30 | 13G | Fulcrum Therapeutics, Inc. FULC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,182,791 2.200% |
-4,336,090 (-78.57%) |
Filing History |
| 2024-11-14 4:18 pm Sale |
2024-09-30 | 13G | Mereo BioPharma Group plc MREO |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-36,854,190 (Position Closed) |
Filing History |